Hong Kong Stock Movement | IVD MEDICAL (01931) Surges Over 11% as Subsidiary Successfully Develops Dual-Platform Nipah Virus Detection Solution

Stock News

Jan 28

IVD MEDICAL (01931) surged more than 11%. As of the time of writing, the stock was up 11.25%, trading at HK$1.78, with a turnover of HK$20.59 million.

On the news front, on the evening of January 27, IVD MEDICAL announced that its subsidiary, Shenzhen Tanhua Biotechnology Co., Ltd. ("Tanhua Biotechnology"), has successfully developed a dual-platform detection solution for the Nipah virus, possessing full-process technical support capabilities from rapid screening to precise traceability.

The dual-platform refers to the intelligent fluorescent PCR rapid detection platform and the high-throughput sequencing and intelligent analysis platform.

The announcement stated that the rapid implementation of this Nipah virus detection capability is not only a reflection of Tanhua Biotechnology's technical strength but also a crucial component in the advancement of IVD MEDICAL's overall AI healthcare strategy.

With the company's acquisition of Chuangye Huikang Technology Co., Ltd. (Stock Code: 300451.SZ) progressing steadily (relevant procedures are advancing in an orderly manner), the Group is accelerating the construction of a next-generation public health prevention and control paradigm centered on "AI Early Warning + Rapid Diagnosis + Ecological Synergy".

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1153597851"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153597851\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1153597851?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-28 11:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153597851","market":"sh","top_or_hot":-1,"title":"Hong Kong Stock Movement | IVD MEDICAL (01931) Surges Over 11% as Subsidiary Successfully Develops Dual-Platform Nipah Virus Detection Solution","media":"Stock News","content":"<p>IVD MEDICAL (01931) surged more than 11%. As of the time of writing, the stock was up 11.25%, trading at HK$1.78, with a turnover of HK$20.59 million.</p>\n<p>On the news front, on the evening of January 27, IVD MEDICAL announced that its subsidiary, Shenzhen Tanhua Biotechnology Co., Ltd. (\"Tanhua Biotechnology\"), has successfully developed a dual-platform detection solution for the Nipah virus, possessing full-process technical support capabilities from rapid screening to precise traceability.</p>\n<p>The dual-platform refers to the intelligent fluorescent PCR rapid detection platform and the high-throughput sequencing and intelligent analysis platform.</p>\n<p>The announcement stated that the rapid implementation of this Nipah virus detection capability is not only a reflection of Tanhua Biotechnology's technical strength but also a crucial component in the advancement of IVD MEDICAL's overall AI healthcare strategy.</p>\n<p>With the company's acquisition of Chuangye Huikang Technology Co., Ltd. (Stock Code: 300451.SZ) progressing steadily (relevant procedures are advancing in an orderly manner), the Group is accelerating the construction of a next-generation public health prevention and control paradigm centered on \"AI Early Warning + Rapid Diagnosis + Ecological Synergy\".</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stock Movement | IVD MEDICAL (01931) Surges Over 11% as Subsidiary Successfully Develops Dual-Platform Nipah Virus Detection Solution</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stock Movement | IVD MEDICAL (01931) Surges Over 11% as Subsidiary Successfully Develops Dual-Platform Nipah Virus Detection Solution\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-28 11:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>IVD MEDICAL (01931) surged more than 11%. As of the time of writing, the stock was up 11.25%, trading at HK$1.78, with a turnover of HK$20.59 million.</p>\n<p>On the news front, on the evening of January 27, IVD MEDICAL announced that its subsidiary, Shenzhen Tanhua Biotechnology Co., Ltd. (\"Tanhua Biotechnology\"), has successfully developed a dual-platform detection solution for the Nipah virus, possessing full-process technical support capabilities from rapid screening to precise traceability.</p>\n<p>The dual-platform refers to the intelligent fluorescent PCR rapid detection platform and the high-throughput sequencing and intelligent analysis platform.</p>\n<p>The announcement stated that the rapid implementation of this Nipah virus detection capability is not only a reflection of Tanhua Biotechnology's technical strength but also a crucial component in the advancement of IVD MEDICAL's overall AI healthcare strategy.</p>\n<p>With the company's acquisition of Chuangye Huikang Technology Co., Ltd. (Stock Code: 300451.SZ) progressing steadily (relevant procedures are advancing in an orderly manner), the Group is accelerating the construction of a next-generation public health prevention and control paradigm centered on \"AI Early Warning + Rapid Diagnosis + Ecological Synergy\".</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1197","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"","article_id":"1153597851","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153597851","pubTimestamp":1769571617,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"IVD MEDICAL (01931) surged more than 11%. As of the time of writing, the stock was up 11.25%, trading at HK$1.78, with a turnover of HK$20.59 million. On the news front, on the evening of January 27,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1197":"保健护理产品经销商","01931":"华检医疗"},"translate_title":"港股动向|IVD医疗(01931)大涨超11%子公司成功研发双平台尼帕病毒检测方案","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01931":1},"content_text":"IVD MEDICAL (01931) surged more than 11%. As of the time of writing, the stock was up 11.25%, trading at HK$1.78, with a turnover of HK$20.59 million.\nOn the news front, on the evening of January 27, IVD MEDICAL announced that its subsidiary, Shenzhen Tanhua Biotechnology Co., Ltd. (\"Tanhua Biotechnology\"), has successfully developed a dual-platform detection solution for the Nipah virus, possessing full-process technical support capabilities from rapid screening to precise traceability.\nThe dual-platform refers to the intelligent fluorescent PCR rapid detection platform and the high-throughput sequencing and intelligent analysis platform.\nThe announcement stated that the rapid implementation of this Nipah virus detection capability is not only a reflection of Tanhua Biotechnology's technical strength but also a crucial component in the advancement of IVD MEDICAL's overall AI healthcare strategy.\nWith the company's acquisition of Chuangye Huikang Technology Co., Ltd. (Stock Code: 300451.SZ) progressing steadily (relevant procedures are advancing in an orderly manner), the Group is accelerating the construction of a next-generation public health prevention and control paradigm centered on \"AI Early Warning + Rapid Diagnosis + Ecological Synergy\".","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}